• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:杜雯雯,徐伟,蔡功杰,江欣禅.中国儿童用药可及性分析[J].中国现代应用药学,2018,35(1):128-131.
DU Wenwen,XU Wei,CAI Gongjie,JIANG Xinchan.Analysis of Accessibility about Pediatric Drugs in China[J].Chin J Mod Appl Pharm(中国现代应用药学),2018,35(1):128-131.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2605次   下载 2160 本文二维码信息
码上扫一扫!
分享到: 微信 更多
中国儿童用药可及性分析
杜雯雯, 徐伟, 蔡功杰, 江欣禅
中国药科大学国际医药商学院, 南京 211198
摘要:
目的 了解当前中国医疗机构中儿童用药的可及性现状及存在的问题,为提高儿童用药的可及性提供政策建议。方法 对21省市67家医疗机构进行问卷调研,从儿童用药配备、采购价格、医保覆盖情况、放宽“一品两规”政策执行、配送及供应保障等情况进行研究。结果 各类医疗机构中儿童用药配备不足,儿童用药相较于同通用名的成人用药不具有价格优势,在国家医保目录中儿童用药纳入的品种仍然过少。同时,在各类医疗机构中儿童用药常常出现短缺,部分医疗机构对儿童用药放宽“一品两规”政策执行不到位;且由于儿童用药价格过低,各类医疗机构都普遍存在儿童用药配送不及时的现象。结论 相关部门应围绕儿童用药的供应链环节,继续鼓励儿童用药新品种研发,深化儿童用药在价格、采购和医保支付标准等方面的改革,保障儿童用药生产供应,提高儿童用药的可及性。
关键词:  可及性  儿童用药  医疗机构
DOI:10.13748/j.cnki.issn1007-7693.2018.01.029
分类号:R953
基金项目:
Analysis of Accessibility about Pediatric Drugs in China
DU Wenwen, XU Wei, CAI Gongjie, JIANG Xinchan
School of International Pharmaceutical Business of China Pharmaceutical University, Nanjing 211198, China
Abstract:
OBJECTIVE To learn about the accessibility and problems about the pediatric drugs of medical institutions in China, and then provide the suggestions for improvement. METHODS Researching among the 67 medical institutions with the angles of storage, purchasing price, coverage of medical insurance, liberalization of "one drug with two specifications", dispatching and supply guarantee, ect. RESULTS The storage and amounts in National Health Insurance Directory of pediatric drugs were insufficient. Pediatric drugs had no advantages compared with adult drugs which had the same generic name. At the same time, most pediatric drugs were always shorten in medical institutions, and some institutions hadn't done the "one drug with two specifications" well. Because of the low price, the medical institutions all had the delayed dispatching problems. CONCLUSION The relevant departments should continue to encourage the research and development of new drugs and deepen the reform about the price, dispatching, payment standard of medical insurance. They also should ensure the supply and improve the accessibility in the succeeding work.
Key words:  accessibility  pediatric drugs  medical institutions
扫一扫关注本刊微信